|
US3704108A
(en)
|
1970-09-25 |
1972-11-28 |
Hydrocarbon Research Inc |
Hydroconversion of waste natural and synthetic rubbers
|
|
US4000259A
(en)
|
1975-06-16 |
1976-12-28 |
American Home Products Corporation |
Cyclic dodecapeptide analogs of somatostatin and intermediates
|
|
US4438270A
(en)
|
1977-07-11 |
1984-03-20 |
Merrell Toraude Et Compagnie |
α-Halomethyl derivatives of α-amino acids
|
|
US4191754A
(en)
|
1979-02-28 |
1980-03-04 |
Merck & Co., Inc. |
Bicyclic somatostatin analogs
|
|
US4730006A
(en)
|
1986-01-27 |
1988-03-08 |
Merrell Dow Pharmaceuticals Inc. |
Derivatives of 2,6-diamino-3-haloheptanedioic acid
|
|
WO1989009233A1
(en)
|
1988-03-24 |
1989-10-05 |
Terrapin Technologies, Inc. |
Molecular sticks for controlling protein conformation
|
|
US5120859A
(en)
|
1989-09-22 |
1992-06-09 |
Genentech, Inc. |
Chimeric amino acid analogues
|
|
US5650133A
(en)
|
1990-01-19 |
1997-07-22 |
Nycomed Salutar |
Macrocyclic polyaza dichelates linked through ring nitrogens via an amide or ester functionality
|
|
US5712418A
(en)
|
1989-10-23 |
1998-01-27 |
Research Corporation Technologies, Inc. |
Synthesis and use of amino acid fluorides as peptide coupling reagents
|
|
US5245009A
(en)
|
1990-03-23 |
1993-09-14 |
The Salk Institute For Biological Studies |
CRF antagonists
|
|
CA2047042A1
(en)
|
1990-07-19 |
1992-01-20 |
John Hannah |
Cyclic hiv principal neutralizing determinant peptides
|
|
DE69118826T2
(de)
|
1990-11-27 |
1996-11-14 |
Fuji Photo Film Co Ltd |
Propenamidderivate, deren Polymere, Copolymere und deren Verwendung
|
|
WO1992013878A2
(en)
|
1991-02-07 |
1992-08-20 |
Board Of Trustees Of The University Of Illinois |
Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same
|
|
US5364851A
(en)
|
1991-06-14 |
1994-11-15 |
International Synthecon, Llc |
Conformationally restricted biologically active peptides, methods for their production and uses thereof
|
|
GB9114949D0
(en)
|
1991-07-11 |
1991-08-28 |
Smithkline Beecham Plc |
Novel compounds
|
|
EP0633933A1
(en)
|
1992-03-23 |
1995-01-18 |
Imperial Cancer Research Technology Limited |
Leucine zippers
|
|
JP3067031B2
(ja)
|
1992-04-03 |
2000-07-17 |
カリフォルニア インスティチュート オブ テクノロジー |
オレフィンメタセシス重合方法
|
|
US5411860A
(en)
|
1992-04-07 |
1995-05-02 |
The Johns Hopkins University |
Amplification of human MDM2 gene in human tumors
|
|
AU6770794A
(en)
|
1993-04-23 |
1994-11-21 |
Herbert J. Evans |
Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
|
|
US5446128A
(en)
|
1993-06-18 |
1995-08-29 |
The Board Of Trustees Of The University Of Illinois |
Alpha-helix mimetics and methods relating thereto
|
|
US5622852A
(en)
|
1994-10-31 |
1997-04-22 |
Washington University |
Bcl-x/Bcl-2 associated cell death regulator
|
|
US5536814A
(en)
|
1993-09-27 |
1996-07-16 |
La Jolla Cancer Research Foundation |
Integrin-binding peptides
|
|
US6287787B1
(en)
|
1993-11-24 |
2001-09-11 |
Torrey Pines Institute For Molecular Studies |
Dimeric oligopeptide mixture sets
|
|
US5824483A
(en)
|
1994-05-18 |
1998-10-20 |
Pence Inc. |
Conformationally-restricted combinatiorial library composition and method
|
|
IL109943A
(en)
|
1994-06-08 |
2006-08-01 |
Develogen Israel Ltd |
Conformationally constrained backbone cyclized peptide analogs
|
|
US6407059B1
(en)
|
1994-06-08 |
2002-06-18 |
Peptor Limited |
Conformationally constrained backbone cyclized peptide analogs
|
|
US7553929B2
(en)
|
1994-06-13 |
2009-06-30 |
Vanderbilt University |
Cell permeable peptides for inhibition of inflammatory reactions and methods of use
|
|
US5807746A
(en)
|
1994-06-13 |
1998-09-15 |
Vanderbilt University |
Method for importing biologically active molecules into cells
|
|
US5770377A
(en)
|
1994-07-20 |
1998-06-23 |
University Of Dundee |
Interruption of binding of MDM2 and P53 protein and therapeutic application thereof
|
|
US6169073B1
(en)
|
1995-02-16 |
2001-01-02 |
Bayer Corporation |
Peptides and peptidomimetics with structural similarity to human p53 that activate p53 function
|
|
EP0729972A1
(de)
|
1995-02-28 |
1996-09-04 |
F. Hoffmann-La Roche Ag |
Tetrahydronaphthalin-Peptidderivate
|
|
US5675001A
(en)
|
1995-03-14 |
1997-10-07 |
Hoffman/Barrett, L.L.C. |
Heteroatom-functionalized porphyrazines and multimetallic complexes and polymers derived therefrom
|
|
US5731408A
(en)
|
1995-04-10 |
1998-03-24 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Peptides having potent antagonist and agonist bioactivities at melanocortin receptors
|
|
US6054556A
(en)
|
1995-04-10 |
2000-04-25 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Melanocortin receptor antagonists and agonists
|
|
US5672584A
(en)
|
1995-04-25 |
1997-09-30 |
The University Of Kansas |
Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability
|
|
DK0832096T3
(da)
|
1995-05-04 |
2001-10-01 |
Scripps Research Inst |
Syntese af proteiner ved nativ kemisk ligering
|
|
US6184344B1
(en)
|
1995-05-04 |
2001-02-06 |
The Scripps Research Institute |
Synthesis of proteins by native chemical ligation
|
|
US5730723A
(en)
|
1995-10-10 |
1998-03-24 |
Visionary Medical Products Corporation, Inc. |
Gas pressured needle-less injection device and method
|
|
US6051554A
(en)
|
1995-06-07 |
2000-04-18 |
Peptor Limited |
Conformationally constrained backbone cyclized somatostatin analogs
|
|
US5811515A
(en)
|
1995-06-12 |
1998-09-22 |
California Institute Of Technology |
Synthesis of conformationally restricted amino acids, peptides, and peptidomimetics by catalytic ring closing metathesis
|
|
US5840833A
(en)
|
1995-10-27 |
1998-11-24 |
Molecumetics, Ltd |
Alpha-helix mimetics and methods relating thereto
|
|
US5849954A
(en)
|
1996-01-18 |
1998-12-15 |
Research Corporation Technologies, Inc. |
Method of peptide synthesis
|
|
US5849691A
(en)
|
1996-02-20 |
1998-12-15 |
The United States Of America As Represented By The Department Of Health And Human Services |
Peptidomimetic inhibitors of cathepsin D and plasmepsins I and II
|
|
GB9607549D0
(en)
|
1996-04-11 |
1996-06-12 |
Weston Medical Ltd |
Spring-powered dispensing device
|
|
US5817752A
(en)
|
1996-06-06 |
1998-10-06 |
La Jolla Pharmaceutical Company |
Cyclic polypeptides comprising a thioether linkage and methods for their preparation
|
|
US5663316A
(en)
|
1996-06-18 |
1997-09-02 |
Clontech Laboratories, Inc. |
BBC6 gene for regulation of cell death
|
|
US7083983B2
(en)
|
1996-07-05 |
2006-08-01 |
Cancer Research Campaign Technology Limited |
Inhibitors of the interaction between P53 and MDM2
|
|
EP0958305B1
(en)
|
1996-07-05 |
2008-06-04 |
Cancer Research Technology Limited |
Inhibitions of the interaction between p53 and mdm2
|
|
US20020168761A1
(en)
|
2000-01-24 |
2002-11-14 |
Gour Barbara J. |
Peptidomimetic modulators of cell adhesion
|
|
AU722985B2
(en)
|
1996-07-12 |
2000-08-17 |
Mcgill University |
Compounds and methods for modulating cell adhesion
|
|
US5955593A
(en)
|
1996-09-09 |
1999-09-21 |
Washington University |
BH3 interacting domain death agonist
|
|
US20020064546A1
(en)
|
1996-09-13 |
2002-05-30 |
J. Milton Harris |
Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor
|
|
US5965703A
(en)
|
1996-09-20 |
1999-10-12 |
Idun Pharmaceuticals |
Human bad polypeptides, encoding nucleic acids and methods of use
|
|
US5856445A
(en)
|
1996-10-18 |
1999-01-05 |
Washington University |
Serine substituted mutants of BCL-XL /BCL-2 associated cell death regulator
|
|
US6271198B1
(en)
|
1996-11-06 |
2001-08-07 |
Genentech, Inc. |
Constrained helical peptides and methods of making same
|
|
WO1998022122A1
(en)
|
1996-11-21 |
1998-05-28 |
Promega Corporation |
Alkyl peptide amides and applications
|
|
US7001983B1
(en)
|
1997-02-20 |
2006-02-21 |
Yeda Research And Development Co., Ltd. |
Antipathogenic synthetic peptides and compositions comprising them
|
|
US6849428B1
(en)
|
1997-03-05 |
2005-02-01 |
New England Biolabs, Inc. |
Intein-mediated protein ligation of expressed proteins
|
|
US5851775A
(en)
|
1997-03-20 |
1998-12-22 |
Johns Hopkins University |
β-catenin, Tcf-4, and APC interact to prevent cancer
|
|
WO1998046631A1
(en)
|
1997-04-11 |
1998-10-22 |
Eli Lilly And Company |
Combinatorial libraries of peptidomimetic macrocycles and processes therefor
|
|
EP1015578A4
(en)
|
1997-09-17 |
2004-12-01 |
Walker And Eliza Hall Inst Of |
THERAPEUTIC MOLECULES
|
|
US6165732A
(en)
|
1997-10-14 |
2000-12-26 |
Washington University |
Method for identifying apoptosis modulating compounds
|
|
US6875594B2
(en)
|
1997-11-13 |
2005-04-05 |
The Rockefeller University |
Methods of ligating expressed proteins
|
|
PT1053019E
(pt)
|
1998-01-07 |
2004-04-30 |
Debio Rech Pharma Sa |
Acrilatos de poli(etileno-glicol) heterobifuncional degradaveis e geles e conjugados derivados dos mesmos
|
|
IT1298087B1
(it)
|
1998-01-08 |
1999-12-20 |
Fiderm S R L |
Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
|
|
US6030997A
(en)
|
1998-01-21 |
2000-02-29 |
Eilat; Eran |
Acid labile prodrugs
|
|
FR2775187B1
(fr)
|
1998-02-25 |
2003-02-21 |
Novartis Ag |
Utilisation de l'epothilone b pour la fabrication d'une preparation pharmaceutique antiproliferative et d'une composition comprenant l'epothilone b comme agent antiproliferatif in vivo
|
|
AU767185B2
(en)
|
1998-03-23 |
2003-11-06 |
President And Fellows Of Harvard College |
Synthesis of compounds and libraries of compounds
|
|
CZ20003798A3
(cs)
|
1998-04-15 |
2001-08-15 |
Aventis Pharmaceuticals Products, Inc. |
Způsob výroby cyklických peptidů vázaných k polymernímu nosiči
|
|
US6277824B1
(en)
|
1998-07-10 |
2001-08-21 |
Adherex Technologies |
Compounds and methods for modulating adhesion molecule function
|
|
US6326354B1
(en)
|
1998-08-19 |
2001-12-04 |
Washington University |
Modulation of apoptosis with bid
|
|
US7173005B2
(en)
|
1998-09-02 |
2007-02-06 |
Antyra Inc. |
Insulin and IGF-1 receptor agonists and antagonists
|
|
JP2003503008A
(ja)
|
1999-03-01 |
2003-01-28 |
バリアジェニックス インコーポレーテッド |
Ｒｎａ分子をターゲティングする方法
|
|
CA2368431C
(en)
|
1999-03-29 |
2006-01-24 |
The Procter & Gamble Company |
Melanocortin receptor ligands
|
|
US6713280B1
(en)
|
1999-04-07 |
2004-03-30 |
Thomas Jefferson University |
Enhancement of peptide cellular uptake
|
|
US7192713B1
(en)
|
1999-05-18 |
2007-03-20 |
President And Fellows Of Harvard College |
Stabilized compounds having secondary structure motifs
|
|
CA2284459C
(en)
|
1999-10-04 |
2012-12-11 |
Neokimia Inc. |
Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
|
|
US6348558B1
(en)
|
1999-12-10 |
2002-02-19 |
Shearwater Corporation |
Hydrolytically degradable polymers and hydrogels made therefrom
|
|
DE10009341A1
(de)
|
2000-02-22 |
2001-09-06 |
Florian Kern |
Verfahren zur antigen-spezifischen Stimulation von T-Lymphozyten
|
|
US6495674B1
(en)
|
2000-02-25 |
2002-12-17 |
The Salk Institute For Biological Studies |
Evectins and their use
|
|
US7049290B2
(en)
|
2000-07-28 |
2006-05-23 |
Universität Zürich |
Essential downstream component of the wingless signaling pathway and therapeutic and diagnostic applications based thereon
|
|
WO2002013833A2
(en)
|
2000-08-16 |
2002-02-21 |
Georgetown University Medical Center |
SMALL MOLECULE INHIBITORS TARGETED AT Bcl-2
|
|
CA2432111A1
(en)
|
2000-12-19 |
2002-08-22 |
The Johns Hopkins University |
Jfy1 protein induces rapid apoptosis
|
|
WO2002072597A2
(en)
|
2001-03-09 |
2002-09-19 |
University Of Louisville |
Helicomimetics and stabilized lxxll peptidomimetics
|
|
US20040106548A1
(en)
|
2001-09-07 |
2004-06-03 |
Schmidt Michelle A |
Conformationally constrained labeled peptides for imaging and therapy
|
|
WO2003057158A2
(en)
|
2001-12-31 |
2003-07-17 |
Dana-Farber Cancer Institute, Inc. |
Method of treating apoptosis and compositions thereof
|
|
EP1468013A4
(en)
|
2002-01-03 |
2005-03-16 |
Yissum Res Dev Co |
CYCLIC PEPTIDES WITH CARBON SKELETON HAVING RESTRICTED CONFORMATION
|
|
AU2003211093A1
(en)
|
2002-02-15 |
2003-09-09 |
The Regents Of The University Of Michigan |
Inhibitors of rgs proteins
|
|
US20030166138A1
(en)
|
2002-02-21 |
2003-09-04 |
Todd Kinsella |
Cyclic peptides and analogs useful to treat allergies
|
|
EP1499895B1
(en)
|
2002-04-22 |
2008-05-07 |
University Of Florida |
Functionalized nanoparticles and methods of use
|
|
JP4638225B2
(ja)
|
2002-05-30 |
2011-02-23 |
ザ スクリプス リサーチ インスティテュート |
銅を触媒とするアジドとアセチレンのライゲーション
|
|
SE0201863D0
(en)
|
2002-06-18 |
2002-06-18 |
Cepep Ab |
Cell penetrating peptides
|
|
AU2003261774A1
(en)
|
2002-09-06 |
2004-03-29 |
Kaneka Corporation |
PROCESS FOR PRODUCING L-Alpha-METHYLCYSTEINE DERIVATIVE
|
|
US20040171809A1
(en)
|
2002-09-09 |
2004-09-02 |
Korsmeyer Stanley J. |
BH3 peptides and method of use thereof
|
|
WO2004026896A2
(en)
|
2002-09-23 |
2004-04-01 |
Medivir Ab |
Hcv ns-3 serine protease inhibitors
|
|
EP1562941B1
(en)
|
2002-11-07 |
2009-12-23 |
Kosan Biosciences, Inc. |
Trans-9,10-dehydroepothilone c and d, analogs thereof and methos of making the same
|
|
CA2503117C
(en)
|
2002-11-08 |
2010-12-21 |
F. Hoffmann-La Roche Ag |
Substituted 4-alkoxyoxazol derivatives as ppar agonists
|
|
US7166575B2
(en)
|
2002-12-17 |
2007-01-23 |
Nastech Pharmaceutical Company Inc. |
Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesity
|
|
WO2004058804A1
(en)
|
2002-12-24 |
2004-07-15 |
Walter And Eliza Hall Institute Of Medical Research |
Peptides and therapeutic uses thereof
|
|
EP1452868A2
(en)
|
2003-02-27 |
2004-09-01 |
Pepscan Systems B.V. |
Method for selecting a candidate drug compound
|
|
AU2003902743A0
(en)
|
2003-06-02 |
2003-06-19 |
Promics Pty Limited |
Process for the preparation of cyclic peptides
|
|
WO2005007675A2
(en)
|
2003-07-09 |
2005-01-27 |
The Scripps Research Institute |
TRIAZOLE ϵ-AMINO ACIDS
|
|
GB0317815D0
(en)
|
2003-07-30 |
2003-09-03 |
Amersham Health As |
Imaging agents
|
|
EP1673078B1
(en)
|
2003-10-03 |
2008-05-28 |
Merck & Co., Inc. |
Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
|
|
JP2007537989A
(ja)
|
2003-10-16 |
2007-12-27 |
アプラーゲン ゲゼルシャフト ミット ベシュレンクテル ハフツング |
安定化ペプチド
|
|
ES2586387T3
(es)
|
2003-11-05 |
2016-10-14 |
Dana-Farber Cancer Institute, Inc. |
Péptidos alfa helicoidales adecuados para activar o inhibir la muerte celular
|
|
GB0404731D0
(en)
|
2004-03-03 |
2004-04-07 |
Indp Administrative Inst Nims |
Method and products for the selective degradation of proteins
|
|
WO2005090388A1
(en)
|
2004-03-19 |
2005-09-29 |
The University Of Queensland |
Alpha helical mimics, their uses and methods for their production
|
|
US7202332B2
(en)
|
2004-05-27 |
2007-04-10 |
New York University |
Methods for preparing internally constrained peptides and peptidomimetics
|
|
EP1602663A1
(en)
|
2004-06-04 |
2005-12-07 |
Chiralix B.V. |
Triazole-linked glycoamino acids and glycopeptides
|
|
US7501397B2
(en)
|
2004-06-04 |
2009-03-10 |
The Brigham And Women's Hospital, Inc. |
Helical peptidomimetics with enhanced activity
|
|
CN100335467C
(zh)
|
2004-06-04 |
2007-09-05 |
中国科学院上海有机化学研究所 |
一锅法区域选择性合成5－碘代－1，4－二取代－1，2，3－三氮唑化合物
|
|
DE102004033312A1
(de)
|
2004-07-08 |
2006-01-26 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Kontinuierliches Metatheseverfahren mit Ruthenium-Katalysatoren
|
|
EP1765378B1
(en)
|
2004-07-12 |
2014-04-16 |
Medical Research Fund of Tel Aviv Sourasky Medical Center |
Agent capable of downregulating an msf-a-dependent hif-1a and use thereof in cancer treatment
|
|
ES2326750T3
(es)
|
2004-10-29 |
2009-10-19 |
Schering Corporation |
5-carboxiamido pirazoles y (1,2,4) triazoles como agentes antivirales.
|
|
US20060148715A1
(en)
|
2004-12-20 |
2006-07-06 |
Baylor College Of Medicine |
Structural requirements for STAT3 binding and recruitment to phosphotyrosine ligands
|
|
WO2006078161A1
(en)
|
2005-01-24 |
2006-07-27 |
Pepscan Systems B.V. |
Binding compounds, immunogenic compounds and peptidomimetics
|
|
WO2006103666A2
(en)
|
2005-03-28 |
2006-10-05 |
Yeda Research And Development Co. Ltd. |
Isolated bid polypeptides, polynucleotides encoding same and antibodies directed thereagainst and methods of using same for inducing cell cycle arrest or apoptosis
|
|
US20070020620A1
(en)
|
2005-07-14 |
2007-01-25 |
Finn M G |
Compositions and methods for coupling a plurality of compounds to a scaffold
|
|
US20070161544A1
(en)
|
2006-01-06 |
2007-07-12 |
Peter Wipf |
Selective targeting agents for mitcochondria
|
|
US7745573B2
(en)
|
2006-02-17 |
2010-06-29 |
Polychip Pharmaceuticals Pty Ltd. |
Conotoxin analogues and methods for synthesis of intramolecular dicarba bridge-containing peptides
|
|
US7538190B2
(en)
|
2006-02-17 |
2009-05-26 |
Polychip Pharmaceuticals Pty Ltd |
Methods for the synthesis of two or more dicarba bridges in organic compounds
|
|
GB0611405D0
(en)
|
2006-06-09 |
2006-07-19 |
Univ Belfast |
FKBP-L: A novel inhibitor of angiogenesis
|
|
WO2007144886A2
(en)
|
2006-06-15 |
2007-12-21 |
Ben-Gurion University Of The Negev Research And Development Authority |
Virus-like particles for treatment of viral infections
|
|
JP2009544697A
(ja)
|
2006-07-26 |
2009-12-17 |
ペプスキャン システムズ ベー．フェー． |
免疫原性化合物及びタンパク質擬態物
|
|
US20080213175A1
(en)
|
2006-09-15 |
2008-09-04 |
Kolb Hartmuth C |
Click chemistry-derived cyclic peptidomimetics as integrin markers
|
|
EP2073829B1
(en)
|
2006-10-05 |
2012-06-20 |
New York Blood Center, Inc. |
Stabilized therapeutic small helical antiviral peptides
|
|
EP2997973A1
(en)
|
2006-11-15 |
2016-03-23 |
Dana-Farber Cancer Institute, Inc. |
Stabalized maml peptides and uses thereof
|
|
US7932397B2
(en)
|
2006-11-22 |
2011-04-26 |
Massachusetts Institute Of Technology |
Olefin metathesis catalysts and related methods
|
|
BRPI0720306A2
(pt)
*
|
2006-12-14 |
2014-02-04 |
Aileron Therapeutics Inc |
Sistemas de macrociclização da bis-sufidrila
|
|
US7981998B2
(en)
|
2006-12-14 |
2011-07-19 |
Aileron Therapeutics, Inc. |
Bis-sulfhydryl macrocyclization systems
|
|
EP2121007A1
(en)
|
2006-12-21 |
2009-11-25 |
Cytos Biotechnology AG |
Circular ccr5 peptide conjugates and uses thereof
|
|
DK2118123T3
(en)
|
2007-01-31 |
2016-01-25 |
Dana Farber Cancer Inst Inc |
Stabilized p53 peptides and uses thereof
|
|
ES2649941T3
(es)
|
2007-02-23 |
2018-01-16 |
Aileron Therapeutics, Inc. |
Aminoácidos sustituidos para preparar péptidos macrocíclicos unidos a triazol
|
|
US8592377B2
(en)
|
2007-03-28 |
2013-11-26 |
President And Fellows Of Harvard College |
Stitched polypeptides
|
|
CA2685568A1
(en)
|
2007-05-02 |
2008-11-13 |
Dana-Farber Cancer Institute, Inc. |
Methods of treating diabetes using bad bh3 domain peptide
|
|
CA2700925C
(en)
|
2007-09-26 |
2016-08-23 |
Dana Farber Cancer Institute |
Methods and compositions for modulating bcl-2 family polypeptides
|
|
WO2009110952A2
(en)
|
2007-12-31 |
2009-09-11 |
New York University |
Control of viral-host membrane fusion with hydrogen bond surrogate-based artificial helices
|
|
JP6157046B2
(ja)
|
2008-01-07 |
2017-07-05 |
アムジェン インコーポレイテッド |
静電的ステアリング（ｅｌｅｃｔｒｏｓｔａｔｉｃｓｔｅｅｒｉｎｇ）効果を用いた抗体Ｆｃヘテロ二量体分子を作製するための方法
|
|
EP2247606B1
(en)
|
2008-01-23 |
2019-08-21 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for the treatment of viral infections
|
|
BRPI0906685A2
(pt)
|
2008-01-25 |
2016-10-11 |
Massachusetts Inst Technology |
catalisadores para reações de metátese incluindo metátese de olefina enantiosseletiva, e métodos relacionados
|
|
DE112009000300T5
(de)
|
2008-02-08 |
2011-01-20 |
Aileron Therapeutics, Inc., Cambridge |
Therapeutische Peptidomimetische Makrocyclen
|
|
US20110144303A1
(en)
|
2008-04-08 |
2011-06-16 |
Aileron Therapeutics, Inc. |
Biologically Active Peptidomimetic Macrocycles
|
|
EP2310407A4
(en)
|
2008-04-08 |
2011-09-14 |
Aileron Therapeutics Inc |
BIOLOGIC EFFECTIVE PEPTIDOMIMETIC MACROCYCLES
|
|
WO2009149214A2
(en)
|
2008-06-03 |
2009-12-10 |
Aileron Therapeutics, Inc. |
Compositions and methods for enhancing cellular transport of biomolecules
|
|
EP2356139A4
(en)
|
2008-07-23 |
2013-01-09 |
Harvard College |
LIGURE COMBINED POLYPEPTIDES
|
|
WO2010033879A2
(en)
|
2008-09-18 |
2010-03-25 |
New York University |
Inhibiting interaction between hif-1a and p300/cbp with hydrogen bond surrogate-based helices
|
|
WO2010034026A1
(en)
|
2008-09-22 |
2010-03-25 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
US20120115783A1
(en)
|
2008-09-22 |
2012-05-10 |
Alleron therapeutics, Inc |
Peptidomimetic macrocycles
|
|
BRPI0920889A2
(pt)
|
2008-09-22 |
2017-10-10 |
Aileron Therapeutics Inc |
macrociclos peptidomiméticos.
|
|
CN102197048A
(zh)
|
2008-09-22 |
2011-09-21 |
爱勒让治疗公司 |
拟肽大环化合物
|
|
CA2737922A1
(en)
|
2008-09-22 |
2010-03-25 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
CN102203126A
(zh)
|
2008-09-22 |
2011-09-28 |
爱勒让治疗公司 |
用于制备纯化的多肽组合物的方法
|
|
BRPI0920899A2
(pt)
|
2008-11-24 |
2016-04-26 |
Aileron Therapeutics Inc |
macrociclos peptidomiméticos com propriedades melhoradas
|
|
EP3549951A3
(en)
|
2008-12-09 |
2019-11-20 |
Dana Farber Cancer Institute, Inc. |
Methods and compositions for specific modulation of mcl-1
|
|
US9175047B2
(en)
|
2009-01-14 |
2015-11-03 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
AU2010273220B2
(en)
|
2009-07-13 |
2015-10-15 |
President And Fellows Of Harvard College |
Bifunctional stapled polypeptides and uses thereof
|
|
CN102712675A
(zh)
|
2009-09-22 |
2012-10-03 |
爱勒让治疗公司 |
拟肽大环化合物
|
|
US20110223149A1
(en)
|
2009-10-14 |
2011-09-15 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
US8598400B2
(en)
|
2010-02-08 |
2013-12-03 |
Massachusetts Institute Of Technology |
Efficient methods for Z- or cis-selective cross-metathesis
|
|
US20130177979A1
(en)
|
2010-06-22 |
2013-07-11 |
University Of Central Florida Research Foundation, Inc. |
Methods and compositions for cell permeable stat3 inhibitor
|
|
ES2711526T3
(es)
|
2010-08-13 |
2019-05-06 |
Aileron Therapeutics Inc |
Macrociclos peptidomiméticos
|
|
WO2012040459A2
(en)
|
2010-09-22 |
2012-03-29 |
President And Fellows Of Harvard College |
Beta-catenin targeting peptides and uses thereof
|
|
ES2586411T3
(es)
|
2011-03-04 |
2016-10-14 |
New York University |
Macrociclos sustitutos de enlace de hidrógeno como moduladores de Ras
|
|
WO2012173846A2
(en)
|
2011-06-06 |
2012-12-20 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
US9487562B2
(en)
|
2011-06-17 |
2016-11-08 |
President And Fellows Of Harvard College |
Stabilized polypeptides as regulators of RAB GTPase function
|
|
WO2012174409A1
(en)
|
2011-06-17 |
2012-12-20 |
President And Fellows Of Harvard College |
Stabilized variant maml peptides and uses thereof
|
|
CN103889437A
(zh)
|
2011-08-31 |
2014-06-25 |
纽约大学 |
硫醚、醚和烷基胺连接的氢键替代物肽模拟物
|
|
TW201806968A
(zh)
|
2011-10-18 |
2018-03-01 |
艾利倫治療公司 |
擬肽巨環化合物
|
|
WO2013059530A2
(en)
|
2011-10-18 |
2013-04-25 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
EP2819688A4
(en)
|
2012-02-15 |
2015-10-28 |
Aileron Therapeutics Inc |
TRIAZOL AND THIOETHER-COUPLED PEPTIDOMIMETIC MACROCYCLES
|
|
BR112014020103A2
(pt)
|
2012-02-15 |
2018-10-09 |
Aileron Therapeutics, Inc. |
macrociclos peptidomiméticos
|
|
WO2014052647A2
(en)
|
2012-09-26 |
2014-04-03 |
President And Fellows Of Harvard College |
Proline-locked stapled peptides and uses thereof
|
|
US20150225471A1
(en)
|
2012-10-01 |
2015-08-13 |
President And Fellows Of Harvard College |
Stabilized polypeptide insulin receptor modulators
|
|
WO2014071241A1
(en)
|
2012-11-01 |
2014-05-08 |
Aileron Therapeutics, Inc. |
Disubstituted amino acids and methods of preparation and use thereof
|
|
WO2014138429A2
(en)
|
2013-03-06 |
2014-09-12 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and use thereof in regulating hif1alpha
|
|
WO2015157508A1
(en)
|
2014-04-09 |
2015-10-15 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles with pth activity
|
|
EP3197478A4
(en)
|
2014-09-24 |
2018-05-30 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
|
AU2015320545C1
(en)
|
2014-09-24 |
2020-05-14 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and formulations thereof
|
|
WO2016154058A1
(en)
|
2015-03-20 |
2016-09-29 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
|
US10059741B2
(en)
|
2015-07-01 |
2018-08-28 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
EP3317294B1
(en)
|
2015-07-02 |
2023-03-15 |
Dana-Farber Cancer Institute, Inc. |
Stabilized anti-microbial peptides
|
|
US20170037105A1
(en)
|
2015-08-03 |
2017-02-09 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
US20170114098A1
(en)
|
2015-09-03 |
2017-04-27 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
|
WO2017044633A1
(en)
|
2015-09-10 |
2017-03-16 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles as modulators of mcl-1
|
|
US20170360881A1
(en)
|
2016-06-17 |
2017-12-21 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|